FY13 Half Yearly Report
26 February 2013 – Craneware plc (AIM: CRW.L), the market leader in automated revenue integrity solutions for the US healthcare market, announces its unaudited results for the six months ended 31 December 2012
Financial Highlights (US dollars)
- Revenue increased 7% to $20.1m (H112: $18.8m)
- Adjusted EBITDA1 increased 15% to $5.4m (H112: $4.7m )
- Profit before tax $4.5m (H112: $3.8m)
- Adjusted basic EPS increased 18% to 13.2 cents per share (H112: 11.2 cents)
- Cash at period end $28.6m (H112: $23.6m) from $28.8m at 30 June 2012
- Proposed interim dividend of 5.2p (H112: 4.8p per share)
1. Adjusted EBITDA refers to earnings before interest, tax, depreciation, amortisation, share based payments and transaction related costs.
Operational Highlights
- 2012 Best in KLAS Awards: Software & Services
- Particularly strong performance from InSight Audit
- Supportive market environment
- Good revenue visibility over the remainder of the year
Keith Neilson, CEO of Craneware commented:
“This has been a positive trading period for Craneware. Sales activity is ahead of the same period last year and is now starting to translate into revenue growth. The relevance of our product set continues to strengthen in the evolving healthcare landscape with the developments within the US healthcare market supportive of the Group’s long-term strategy and growth.”
For further information, please contact:
Craneware plc
- +44 (0) 131 550 3100
- Keith Neilson, CEO
- Craig Preston, CFO
Peel Hunt
- +44 (0) 20 7418 8900
- Dan Webster
- Richard Kauffer
Newgate Threadneedle
- +44 (0) 20 7653 9850
- Caroline Evans-Jones
- Fiona Conroy
- Heather Armstrong
About Craneware
Craneware is the leader in automated revenue integrity solutions that improve financial performance and mitigate risk for US healthcare organisations. Founded in 1999, Craneware has headquarters in Edinburgh, Scotland with offices in Atlanta, Boston, Nashville and Phoenix employing more than 200 staff. Craneware’s market-driven, SaaS solutions help hospitals and other healthcare providers more effectively price, charge, code and retain earned revenue for patient care services and supplies. This optimises reimbursement, increases operational efficiency and minimises compliance risk. By partnering with Craneware, clients achieve the visibility required to identify, address and prevent revenue leakage. To learn more, visit craneware.com.
Share the Love!
You might also like...
Array
(
[posts_per_page] => 1
[cat] => 36
[paged] => 1
[post__not_in] => Array
(
[0] => 353
)
)
WP_Query Object
(
[query] => Array
(
[posts_per_page] => 1
[cat] => 36
[paged] => 1
[post__not_in] => Array
(
[0] => 353
)
)
[query_vars] => Array
(
[posts_per_page] => 1
[cat] => 36
[paged] => 1
[post__not_in] => Array
(
[0] => 353
)
[error] =>
[m] =>
[p] => 0
[post_parent] =>
[subpost] =>
[subpost_id] =>
[attachment] =>
[attachment_id] => 0
[name] =>
[static] =>
[pagename] =>
[page_id] => 0
[second] =>
[minute] =>
[hour] =>
[day] => 0
[monthnum] => 0
[year] => 0
[w] => 0
[category_name] => announcements
[tag] =>
[tag_id] =>
[author] =>
[author_name] =>
[feed] =>
[tb] =>
[meta_key] =>
[meta_value] =>
[preview] =>
[s] =>
[sentence] =>
[title] =>
[fields] =>
[menu_order] =>
[embed] =>
[category__in] => Array
(
)
[category__not_in] => Array
(
)
[category__and] => Array
(
)
[post__in] => Array
(
)
[post_name__in] => Array
(
)
[tag__in] => Array
(
)
[tag__not_in] => Array
(
)
[tag__and] => Array
(
)
[tag_slug__in] => Array
(
)
[tag_slug__and] => Array
(
)
[post_parent__in] => Array
(
)
[post_parent__not_in] => Array
(
)
[author__in] => Array
(
)
[author__not_in] => Array
(
)
[ignore_sticky_posts] =>
[suppress_filters] =>
[cache_results] => 1
[update_post_term_cache] => 1
[lazy_load_term_meta] => 1
[update_post_meta_cache] => 1
[post_type] =>
[nopaging] =>
[comments_per_page] => 50
[no_found_rows] =>
[order] => DESC
)
[tax_query] => WP_Tax_Query Object
(
[queries] => Array
(
[0] => Array
(
[taxonomy] => category
[terms] => Array
(
[0] => 36
)
[field] => term_id
[operator] => IN
[include_children] => 1
)
)
[relation] => AND
[table_aliases:protected] => Array
(
[0] => wp_term_relationships
)
[queried_terms] => Array
(
[category] => Array
(
[terms] => Array
(
[0] => 36
)
[field] => term_id
)
)
[primary_table] => wp_posts
[primary_id_column] => ID
)
[meta_query] => WP_Meta_Query Object
(
[queries] => Array
(
)
[relation] =>
[meta_table] =>
[meta_id_column] =>
[primary_table] =>
[primary_id_column] =>
[table_aliases:protected] => Array
(
)
[clauses:protected] => Array
(
)
[has_or_relation:protected] =>
)
[date_query] =>
[request] => SELECT SQL_CALC_FOUND_ROWS wp_posts.ID FROM wp_posts LEFT JOIN wp_term_relationships ON (wp_posts.ID = wp_term_relationships.object_id) WHERE 1=1 AND wp_posts.ID NOT IN (353) AND (
wp_term_relationships.term_taxonomy_id IN (36)
) AND wp_posts.post_type = 'post' AND (wp_posts.post_status = 'publish') GROUP BY wp_posts.ID ORDER BY wp_posts.post_date DESC LIMIT 0, 1
[posts] => Array
(
[0] => WP_Post Object
(
[ID] => 205203
[post_author] => 2
[post_date] => 2018-07-10 06:31:35
[post_date_gmt] => 2018-07-10 06:31:35
[post_content] => [et_pb_section bb_built="1" next_background_color="#000000" _builder_version="3.0.106" module_class="article-post"][et_pb_row][et_pb_column type="4_4"][et_pb_text _builder_version="3.2.2"]
10 July 2018 - Craneware (AIM: CRW.L), the market leader in Value Cycle solutions for the US healthcare market, provides an update on trading for the year ended 30 June 2018.
The Group is pleased to announce continued outstanding performance, as it executes on its growth strategy. There has been strong underlying new sales growth that increased by approximately 100%. This includes a further significant new contract signed at the end of the year. This contract with a large healthcare provider network ('the Network') in the Eastern US is for the Company's Pharmacy ChargeLink® solution. Further details on the contract are provided below.
Renewals by dollar value have continued at over 100% in the period. In accordance with the Company's revenue recognition policy, the majority of the revenue resulting from both new and renewal sales successes will be recognised over future periods, adding significantly to the acceleration of the Group's long term visibility of revenue under contract.
In addition to this record sales performance, the Group expects to report increases of approximately 16% in revenue and 20% in adjusted EBITDA for the year ended 30 June 2018, extending the run of organic double digit growth delivered in prior years.
Having returned $15m to shareholders and invested a further $4m in the Employee Benefit Trust during the year, the Group's cash conversion has resulted in the cash balances returning to similar levels to those seen at the end of FY17 (FY17: $53m).
Further Significant Contract Win
Craneware has signed a significant new contract, with a large hospital network in the Eastern US, for its Pharmacy ChargeLink® solution. From October 2018, Craneware's solution will be rolled out to the 12 facilities across the Network. This contract is expected to deliver in excess of $6m of revenue over its initial five year term. As per the revenue recognition policy all of the revenue from this contract will be recognised in future periods.
Notice of Results
The Company will announce results for the year ended 30 June 2018 on 4 Sept 2018.
Keith Neilson, CEO of Craneware plc, commented, "These record results demonstrate the ongoing momentum we are seeing across all strata of hospitals including large and complex health systems as they embrace the realities of value-based economics within healthcare.
"The strength of our solutions and the value they deliver to our customers, allows us to support our customers as they address the challenges resulting from the continued evolution of the US Healthcare market. We are playing an increasingly strategic role in assisting healthcare providers to deliver better healthcare through sustainable financial performance, whilst mitigating operational and compliance risks.
"These factors combined with our financial strength and high levels of visible revenue for future years, gives management confidence in its continuing ability to deliver increasing stakeholder value year on year whilst investing in our future."
For further information, please contact:
Craneware plc
- +44 (0)131 550 3100
- Keith Neilson, CEO
- Craig Preston, CFO
Peel Hunt
- +44 (0)20 7418 8900
- Dan Webster
- Adrian Trimmings
Alma
- +44 (0)208 004 4217
- Caroline Forde
- Robyn Fisher
- Josh Royston
About Craneware
Craneware enables healthcare providers to improve margins and enhance patient outcomes so they can continue to provide quality outcomes for all.
Craneware is the leader in automated value cycle solutions that help US Healthcare provider organisations discover, convert and optimise assets to achieve best clinical outcomes and financial performance. Founded in 1999, Craneware is headquartered in Edinburgh, Scotland with offices in Atlanta, Boston and Pittsburgh employing over 250 staff. Craneware's market-driven, SaaS solutions normalise disparate data sets, bringing in up-to-date regulatory and financial compliance data to deliver value at the points where clinical and operational data transform into financial transactions, creating actionable insights that enable informed tactical and strategic decisions. To learn more, visit craneware.com and thevaluecycle.com.
[/et_pb_text][/et_pb_column][/et_pb_row][/et_pb_section][et_pb_section bb_built="1" _builder_version="3.0.89" custom_padding="0px|||" prev_background_color="#000000" next_background_color="#e6eaee" global_module="25686"][et_pb_row global_parent="25686" module_class="social-share-blog" _builder_version="3.0.90" background_size="initial" background_position="top_left" background_repeat="repeat" module_alignment="center"][et_pb_column type="4_4"][et_pb_divider global_parent="25686" color="#d7d7d7" height="5px" _builder_version="3.2" max_width="80%" module_alignment="center" custom_padding="||40px|" /][et_pb_text global_parent="25686" _builder_version="3.0.106" module_alignment="center"]
Share the Love!
[/et_pb_text][et_pb_image global_parent="25686" src="https://craneware.wpengine.com/wp-content/uploads/2018/03/twitter-share.png" url="https://twitter.com/home?status=" align="center" module_class="share-icon twitter" _builder_version="3.2.2" /][et_pb_image global_parent="25686" src="https://craneware.wpengine.com/wp-content/uploads/2018/06/linkedin_share.png" url="https://www.linkedin.com/shareArticle?mini=true&url=" align="center" module_class="share-icon linkedin" _builder_version="3.2.2" /][/et_pb_column][/et_pb_row][/et_pb_section][et_pb_section bb_built="1" fullwidth="off" specialty="off" _builder_version="3.0.106" background_color="#e6eaee" module_class="related-background" prev_background_color="#ffffff" next_background_color="#2d79c2" global_module="26303"][et_pb_row global_parent="26303" background_position="top_left" background_repeat="repeat" background_size="initial"][et_pb_column type="4_4"][et_pb_text global_parent="26303" _builder_version="3.0.90" background_layout="light"]
You might also like...
[/et_pb_text][/et_pb_column][/et_pb_row][et_pb_row global_parent="26303" background_position="top_left" background_repeat="repeat" background_size="initial" _builder_version="3.2.2"][et_pb_column type="1_3"][et_pb_blog global_parent="26303" _builder_version="3.2.2" posts_number="1" include_categories="36" show_content="off" show_thumbnail="off" show_more="on" show_author="off" show_date="on" show_categories="on" show_comments="off" show_pagination="off" fullwidth="on" use_overlay="off" background_layout="light" pagination_font_size_tablet="51" pagination_line_height_tablet="2" use_dropshadow="off" offset_number="0" /][/et_pb_column][et_pb_column type="1_3"][et_pb_blog global_parent="26303" _builder_version="3.2.2" posts_number="1" include_categories="36" show_content="off" show_thumbnail="off" show_more="on" show_author="off" show_date="on" show_categories="on" show_comments="off" show_pagination="off" fullwidth="on" use_overlay="off" background_layout="light" pagination_font_size_tablet="51" pagination_line_height_tablet="2" offset_number="1" use_dropshadow="off" /][/et_pb_column][et_pb_column type="1_3"][et_pb_blog global_parent="26303" _builder_version="3.2.2" posts_number="1" include_categories="36" show_content="off" show_thumbnail="off" show_more="on" show_author="off" show_date="on" show_categories="on" show_comments="off" show_pagination="off" fullwidth="on" use_overlay="off" background_layout="light" pagination_font_size_tablet="51" pagination_line_height_tablet="2" offset_number="2" use_dropshadow="off" /][/et_pb_column][/et_pb_row][/et_pb_section][et_pb_section bb_built="1" background_color="#2d79c2" module_class="cta-background" _builder_version="3.0.106" use_background_color_gradient="on" background_color_gradient_start="#296ab0" background_color_gradient_end="#2b71ba" background_color_gradient_type="radial" prev_background_color="#e6eaee" global_module="20823"][et_pb_row global_parent="20823" _builder_version="3.0.47" background_size="initial" background_position="top_left" background_repeat="repeat"][et_pb_column type="4_4"][et_pb_text global_parent="20823" background_layout="dark" _builder_version="3.0.106" text_font="|600|||||||" text_text_color="#ffffff" header_2_font_size="30px"]
Ready to learn more?
[/et_pb_text][/et_pb_column][/et_pb_row][et_pb_row global_parent="20823" module_class="callout-btns" _builder_version="3.0.106"][et_pb_column type="1_2"][et_pb_button global_parent="20823" button_url="/contact" button_text="Contact Us" background_layout="dark" module_class="footer-cta-btn" _builder_version="3.0.106" custom_button="on" button_text_size="17" button_text_color="#ffffff" button_bg_color="#66bf48" button_border_color="#66bf48" button_border_radius="5" button_use_icon="off"]
[/et_pb_button][/et_pb_column][et_pb_column type="1_2"][et_pb_button admin_label="Desktop Phone" global_parent="20823" button_text="1-877-624-2792" background_layout="dark" module_class="footer-cta-btn desktop-phone" _builder_version="3.2.2" custom_button="on" button_text_size="17" button_text_color="#ffffff" button_bg_color="#66bf48" button_border_color="#66bf48" button_border_radius="5" button_use_icon="off" disabled="off" disabled_on="on|on|" button_bg_color_hover="#66bf48" button_border_color_hover="#66bf48" button_url="#"]
[/et_pb_button][et_pb_button admin_label="Mobile Phone" global_parent="20823" button_url="tel:18005555555" button_text="1-877-624-2792" background_layout="dark" module_class="footer-cta-btn" _builder_version="3.2.2" custom_button="on" button_text_size="17" button_text_color="#ffffff" button_bg_color="#66bf48" button_border_color="#66bf48" button_border_radius="5" button_use_icon="off" disabled="off" disabled_on="||on"]
[/et_pb_button][et_pb_button global_parent="20823" button_url="#" button_text="Chat Now" background_layout="dark" module_id="chat-btn" module_class="footer-cta-btn" _builder_version="3.2.2" custom_button="on" button_text_size="17" button_text_color="#ffffff" button_bg_color="#66bf48" button_border_color="#66bf48" button_border_radius="5" button_use_icon="off" disabled_on="on|on|on" disabled="on"]
[/et_pb_button][/et_pb_column][/et_pb_row][/et_pb_section]
[post_title] => Trading Update and Significant Contract Win
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => open
[post_password] =>
[post_name] => trading-update-and-significant-contract-win
[to_ping] =>
[pinged] =>
[post_modified] => 2018-07-10 06:31:35
[post_modified_gmt] => 2018-07-10 06:31:35
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://public.craneware.com/?p=205203
[menu_order] => 0
[post_type] => post
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
)
[post_count] => 1
[current_post] => -1
[in_the_loop] =>
[post] => WP_Post Object
(
[ID] => 205203
[post_author] => 2
[post_date] => 2018-07-10 06:31:35
[post_date_gmt] => 2018-07-10 06:31:35
[post_content] => [et_pb_section bb_built="1" next_background_color="#000000" _builder_version="3.0.106" module_class="article-post"][et_pb_row][et_pb_column type="4_4"][et_pb_text _builder_version="3.2.2"]
10 July 2018 - Craneware (AIM: CRW.L), the market leader in Value Cycle solutions for the US healthcare market, provides an update on trading for the year ended 30 June 2018.
The Group is pleased to announce continued outstanding performance, as it executes on its growth strategy. There has been strong underlying new sales growth that increased by approximately 100%. This includes a further significant new contract signed at the end of the year. This contract with a large healthcare provider network ('the Network') in the Eastern US is for the Company's Pharmacy ChargeLink® solution. Further details on the contract are provided below.
Renewals by dollar value have continued at over 100% in the period. In accordance with the Company's revenue recognition policy, the majority of the revenue resulting from both new and renewal sales successes will be recognised over future periods, adding significantly to the acceleration of the Group's long term visibility of revenue under contract.
In addition to this record sales performance, the Group expects to report increases of approximately 16% in revenue and 20% in adjusted EBITDA for the year ended 30 June 2018, extending the run of organic double digit growth delivered in prior years.
Having returned $15m to shareholders and invested a further $4m in the Employee Benefit Trust during the year, the Group's cash conversion has resulted in the cash balances returning to similar levels to those seen at the end of FY17 (FY17: $53m).
Further Significant Contract Win
Craneware has signed a significant new contract, with a large hospital network in the Eastern US, for its Pharmacy ChargeLink® solution. From October 2018, Craneware's solution will be rolled out to the 12 facilities across the Network. This contract is expected to deliver in excess of $6m of revenue over its initial five year term. As per the revenue recognition policy all of the revenue from this contract will be recognised in future periods.
Notice of Results
The Company will announce results for the year ended 30 June 2018 on 4 Sept 2018.
Keith Neilson, CEO of Craneware plc, commented, "These record results demonstrate the ongoing momentum we are seeing across all strata of hospitals including large and complex health systems as they embrace the realities of value-based economics within healthcare.
"The strength of our solutions and the value they deliver to our customers, allows us to support our customers as they address the challenges resulting from the continued evolution of the US Healthcare market. We are playing an increasingly strategic role in assisting healthcare providers to deliver better healthcare through sustainable financial performance, whilst mitigating operational and compliance risks.
"These factors combined with our financial strength and high levels of visible revenue for future years, gives management confidence in its continuing ability to deliver increasing stakeholder value year on year whilst investing in our future."
For further information, please contact:
Craneware plc
- +44 (0)131 550 3100
- Keith Neilson, CEO
- Craig Preston, CFO
Peel Hunt
- +44 (0)20 7418 8900
- Dan Webster
- Adrian Trimmings
Alma
- +44 (0)208 004 4217
- Caroline Forde
- Robyn Fisher
- Josh Royston
About Craneware
Craneware enables healthcare providers to improve margins and enhance patient outcomes so they can continue to provide quality outcomes for all.
Craneware is the leader in automated value cycle solutions that help US Healthcare provider organisations discover, convert and optimise assets to achieve best clinical outcomes and financial performance. Founded in 1999, Craneware is headquartered in Edinburgh, Scotland with offices in Atlanta, Boston and Pittsburgh employing over 250 staff. Craneware's market-driven, SaaS solutions normalise disparate data sets, bringing in up-to-date regulatory and financial compliance data to deliver value at the points where clinical and operational data transform into financial transactions, creating actionable insights that enable informed tactical and strategic decisions. To learn more, visit craneware.com and thevaluecycle.com.
[/et_pb_text][/et_pb_column][/et_pb_row][/et_pb_section][et_pb_section bb_built="1" _builder_version="3.0.89" custom_padding="0px|||" prev_background_color="#000000" next_background_color="#e6eaee" global_module="25686"][et_pb_row global_parent="25686" module_class="social-share-blog" _builder_version="3.0.90" background_size="initial" background_position="top_left" background_repeat="repeat" module_alignment="center"][et_pb_column type="4_4"][et_pb_divider global_parent="25686" color="#d7d7d7" height="5px" _builder_version="3.2" max_width="80%" module_alignment="center" custom_padding="||40px|" /][et_pb_text global_parent="25686" _builder_version="3.0.106" module_alignment="center"]
Share the Love!
[/et_pb_text][et_pb_image global_parent="25686" src="https://craneware.wpengine.com/wp-content/uploads/2018/03/twitter-share.png" url="https://twitter.com/home?status=" align="center" module_class="share-icon twitter" _builder_version="3.2.2" /][et_pb_image global_parent="25686" src="https://craneware.wpengine.com/wp-content/uploads/2018/06/linkedin_share.png" url="https://www.linkedin.com/shareArticle?mini=true&url=" align="center" module_class="share-icon linkedin" _builder_version="3.2.2" /][/et_pb_column][/et_pb_row][/et_pb_section][et_pb_section bb_built="1" fullwidth="off" specialty="off" _builder_version="3.0.106" background_color="#e6eaee" module_class="related-background" prev_background_color="#ffffff" next_background_color="#2d79c2" global_module="26303"][et_pb_row global_parent="26303" background_position="top_left" background_repeat="repeat" background_size="initial"][et_pb_column type="4_4"][et_pb_text global_parent="26303" _builder_version="3.0.90" background_layout="light"]
You might also like...
[/et_pb_text][/et_pb_column][/et_pb_row][et_pb_row global_parent="26303" background_position="top_left" background_repeat="repeat" background_size="initial" _builder_version="3.2.2"][et_pb_column type="1_3"][et_pb_blog global_parent="26303" _builder_version="3.2.2" posts_number="1" include_categories="36" show_content="off" show_thumbnail="off" show_more="on" show_author="off" show_date="on" show_categories="on" show_comments="off" show_pagination="off" fullwidth="on" use_overlay="off" background_layout="light" pagination_font_size_tablet="51" pagination_line_height_tablet="2" use_dropshadow="off" offset_number="0" /][/et_pb_column][et_pb_column type="1_3"][et_pb_blog global_parent="26303" _builder_version="3.2.2" posts_number="1" include_categories="36" show_content="off" show_thumbnail="off" show_more="on" show_author="off" show_date="on" show_categories="on" show_comments="off" show_pagination="off" fullwidth="on" use_overlay="off" background_layout="light" pagination_font_size_tablet="51" pagination_line_height_tablet="2" offset_number="1" use_dropshadow="off" /][/et_pb_column][et_pb_column type="1_3"][et_pb_blog global_parent="26303" _builder_version="3.2.2" posts_number="1" include_categories="36" show_content="off" show_thumbnail="off" show_more="on" show_author="off" show_date="on" show_categories="on" show_comments="off" show_pagination="off" fullwidth="on" use_overlay="off" background_layout="light" pagination_font_size_tablet="51" pagination_line_height_tablet="2" offset_number="2" use_dropshadow="off" /][/et_pb_column][/et_pb_row][/et_pb_section][et_pb_section bb_built="1" background_color="#2d79c2" module_class="cta-background" _builder_version="3.0.106" use_background_color_gradient="on" background_color_gradient_start="#296ab0" background_color_gradient_end="#2b71ba" background_color_gradient_type="radial" prev_background_color="#e6eaee" global_module="20823"][et_pb_row global_parent="20823" _builder_version="3.0.47" background_size="initial" background_position="top_left" background_repeat="repeat"][et_pb_column type="4_4"][et_pb_text global_parent="20823" background_layout="dark" _builder_version="3.0.106" text_font="|600|||||||" text_text_color="#ffffff" header_2_font_size="30px"]
Ready to learn more?
[/et_pb_text][/et_pb_column][/et_pb_row][et_pb_row global_parent="20823" module_class="callout-btns" _builder_version="3.0.106"][et_pb_column type="1_2"][et_pb_button global_parent="20823" button_url="/contact" button_text="Contact Us" background_layout="dark" module_class="footer-cta-btn" _builder_version="3.0.106" custom_button="on" button_text_size="17" button_text_color="#ffffff" button_bg_color="#66bf48" button_border_color="#66bf48" button_border_radius="5" button_use_icon="off"]
[/et_pb_button][/et_pb_column][et_pb_column type="1_2"][et_pb_button admin_label="Desktop Phone" global_parent="20823" button_text="1-877-624-2792" background_layout="dark" module_class="footer-cta-btn desktop-phone" _builder_version="3.2.2" custom_button="on" button_text_size="17" button_text_color="#ffffff" button_bg_color="#66bf48" button_border_color="#66bf48" button_border_radius="5" button_use_icon="off" disabled="off" disabled_on="on|on|" button_bg_color_hover="#66bf48" button_border_color_hover="#66bf48" button_url="#"]
[/et_pb_button][et_pb_button admin_label="Mobile Phone" global_parent="20823" button_url="tel:18005555555" button_text="1-877-624-2792" background_layout="dark" module_class="footer-cta-btn" _builder_version="3.2.2" custom_button="on" button_text_size="17" button_text_color="#ffffff" button_bg_color="#66bf48" button_border_color="#66bf48" button_border_radius="5" button_use_icon="off" disabled="off" disabled_on="||on"]
[/et_pb_button][et_pb_button global_parent="20823" button_url="#" button_text="Chat Now" background_layout="dark" module_id="chat-btn" module_class="footer-cta-btn" _builder_version="3.2.2" custom_button="on" button_text_size="17" button_text_color="#ffffff" button_bg_color="#66bf48" button_border_color="#66bf48" button_border_radius="5" button_use_icon="off" disabled_on="on|on|on" disabled="on"]
[/et_pb_button][/et_pb_column][/et_pb_row][/et_pb_section]
[post_title] => Trading Update and Significant Contract Win
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => open
[post_password] =>
[post_name] => trading-update-and-significant-contract-win
[to_ping] =>
[pinged] =>
[post_modified] => 2018-07-10 06:31:35
[post_modified_gmt] => 2018-07-10 06:31:35
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://public.craneware.com/?p=205203
[menu_order] => 0
[post_type] => post
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[comment_count] => 0
[current_comment] => -1
[found_posts] => 193
[max_num_pages] => 193
[max_num_comment_pages] => 0
[is_single] =>
[is_preview] =>
[is_page] =>
[is_archive] => 1
[is_date] =>
[is_year] =>
[is_month] =>
[is_day] =>
[is_time] =>
[is_author] =>
[is_category] => 1
[is_tag] =>
[is_tax] =>
[is_search] =>
[is_feed] =>
[is_comment_feed] =>
[is_trackback] =>
[is_home] =>
[is_404] =>
[is_embed] =>
[is_paged] =>
[is_admin] =>
[is_attachment] =>
[is_singular] =>
[is_robots] =>
[is_posts_page] =>
[is_post_type_archive] =>
[query_vars_hash:WP_Query:private] => 5373a109a1c1a5e259f29f9b9d66096f
[query_vars_changed:WP_Query:private] =>
[thumbnails_cached] =>
[stopwords:WP_Query:private] =>
[compat_fields:WP_Query:private] => Array
(
[0] => query_vars_hash
[1] => query_vars_changed
)
[compat_methods:WP_Query:private] => Array
(
[0] => init_query_flags
[1] => parse_tax_query
)
)
Trading Update and Significant Contract Win
Jul 10, 2018 | Announcements
10 July 2018 - Craneware (AIM: CRW.L), the market leader in Value Cycle solutions for the US healthcare market, provides an update on trading for the year ended 30 June 2018. The Group is pleased to announce continued outstanding...
read moreArray
(
[posts_per_page] => 1
[cat] => 36
[paged] => 1
[offset] => 1
[post__not_in] => Array
(
[0] => 353
)
)
WP_Query Object
(
[query] => Array
(
[posts_per_page] => 1
[cat] => 36
[paged] => 1
[offset] => 1
[post__not_in] => Array
(
[0] => 353
)
)
[query_vars] => Array
(
[posts_per_page] => 1
[cat] => 36
[paged] => 1
[offset] => 1
[post__not_in] => Array
(
[0] => 353
)
[error] =>
[m] =>
[p] => 0
[post_parent] =>
[subpost] =>
[subpost_id] =>
[attachment] =>
[attachment_id] => 0
[name] =>
[static] =>
[pagename] =>
[page_id] => 0
[second] =>
[minute] =>
[hour] =>
[day] => 0
[monthnum] => 0
[year] => 0
[w] => 0
[category_name] => announcements
[tag] =>
[tag_id] =>
[author] =>
[author_name] =>
[feed] =>
[tb] =>
[meta_key] =>
[meta_value] =>
[preview] =>
[s] =>
[sentence] =>
[title] =>
[fields] =>
[menu_order] =>
[embed] =>
[category__in] => Array
(
)
[category__not_in] => Array
(
)
[category__and] => Array
(
)
[post__in] => Array
(
)
[post_name__in] => Array
(
)
[tag__in] => Array
(
)
[tag__not_in] => Array
(
)
[tag__and] => Array
(
)
[tag_slug__in] => Array
(
)
[tag_slug__and] => Array
(
)
[post_parent__in] => Array
(
)
[post_parent__not_in] => Array
(
)
[author__in] => Array
(
)
[author__not_in] => Array
(
)
[ignore_sticky_posts] =>
[suppress_filters] =>
[cache_results] => 1
[update_post_term_cache] => 1
[lazy_load_term_meta] => 1
[update_post_meta_cache] => 1
[post_type] =>
[nopaging] =>
[comments_per_page] => 50
[no_found_rows] =>
[order] => DESC
)
[tax_query] => WP_Tax_Query Object
(
[queries] => Array
(
[0] => Array
(
[taxonomy] => category
[terms] => Array
(
[0] => 36
)
[field] => term_id
[operator] => IN
[include_children] => 1
)
)
[relation] => AND
[table_aliases:protected] => Array
(
[0] => wp_term_relationships
)
[queried_terms] => Array
(
[category] => Array
(
[terms] => Array
(
[0] => 36
)
[field] => term_id
)
)
[primary_table] => wp_posts
[primary_id_column] => ID
)
[meta_query] => WP_Meta_Query Object
(
[queries] => Array
(
)
[relation] =>
[meta_table] =>
[meta_id_column] =>
[primary_table] =>
[primary_id_column] =>
[table_aliases:protected] => Array
(
)
[clauses:protected] => Array
(
)
[has_or_relation:protected] =>
)
[date_query] =>
[request] => SELECT SQL_CALC_FOUND_ROWS wp_posts.ID FROM wp_posts LEFT JOIN wp_term_relationships ON (wp_posts.ID = wp_term_relationships.object_id) WHERE 1=1 AND wp_posts.ID NOT IN (353) AND (
wp_term_relationships.term_taxonomy_id IN (36)
) AND wp_posts.post_type = 'post' AND (wp_posts.post_status = 'publish') GROUP BY wp_posts.ID ORDER BY wp_posts.post_date DESC LIMIT 1, 1
[posts] => Array
(
[0] => WP_Post Object
(
[ID] => 30193
[post_author] => 2
[post_date] => 2018-04-17 15:33:37
[post_date_gmt] => 2018-04-17 15:33:37
[post_content] => [et_pb_section bb_built="1" next_background_color="#000000" _builder_version="3.0.106" module_class="article-post"][et_pb_row][et_pb_column type="4_4"][et_pb_text _builder_version="3.2.2"]
Schedule 6, Block Admission Period to 15 April 2018
This block admission announcement, as required by the AIM Rules, is made every six months and relates to the number of shares that have been issued and allotted during this six month period under the Company's block listing for approved share option plans.
| Name of the company | Craneware plc |
| Names of the schemes | Approved Share Option Plan 2007 |
| Period of return: | 16/10/2017 to 15/4/2018 |
| Balance of unallotted securities under scheme(s) from previous return: | Approved Share Option Plan 2007: 263,781 Ordinary Shares @ 1p each |
| Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | Approved Share Option Plan 2007: 200,000 Ordinary Shares @ 1p each |
| Less: Number of securities issued/allotted under scheme(s) during period: | Approved Share Option Plan 2007: 329,431 Ordinary Shares @ 1p each |
| Equals: Balance under scheme(s) not yet issued/allotted at end of period: | Approved Share Option Plan 2007: 134,350 Ordinary Shares @ 1p each |
| Number and class of securities originally admitted at the date of admission: | 24,929,950 Ordinary Shares of 1p each on 13 September 2007 |
| Contact name and telephone number: | Craig Preston +44 (0) 131 550 3100 |
Share the Love!
[/et_pb_text][et_pb_image global_parent="25686" src="https://craneware.wpengine.com/wp-content/uploads/2018/03/twitter-share.png" url="https://twitter.com/home?status=" align="center" module_class="share-icon twitter" _builder_version="3.2.2" /][et_pb_image global_parent="25686" src="https://craneware.wpengine.com/wp-content/uploads/2018/06/linkedin_share.png" url="https://www.linkedin.com/shareArticle?mini=true&url=" align="center" module_class="share-icon linkedin" _builder_version="3.2.2" /][/et_pb_column][/et_pb_row][/et_pb_section][et_pb_section bb_built="1" fullwidth="off" specialty="off" _builder_version="3.0.106" background_color="#e6eaee" module_class="related-background" prev_background_color="#ffffff" next_background_color="#2d79c2" global_module="26303"][et_pb_row global_parent="26303" background_position="top_left" background_repeat="repeat" background_size="initial"][et_pb_column type="4_4"][et_pb_text global_parent="26303" _builder_version="3.0.90" background_layout="light"]You might also like...
[/et_pb_text][/et_pb_column][/et_pb_row][et_pb_row global_parent="26303" background_position="top_left" background_repeat="repeat" background_size="initial"][et_pb_column type="1_3"][et_pb_blog global_parent="26303" _builder_version="3.0.106" posts_number="1" include_categories="36" show_content="off" show_thumbnail="off" show_more="on" show_author="off" show_date="off" show_categories="on" show_comments="off" show_pagination="off" fullwidth="on" use_overlay="off" background_layout="light" pagination_font_size_tablet="51" pagination_line_height_tablet="2" /][/et_pb_column][et_pb_column type="1_3"][et_pb_blog global_parent="26303" _builder_version="3.0.106" posts_number="1" include_categories="36" show_content="off" show_thumbnail="off" show_more="on" show_author="off" show_date="off" show_categories="on" show_comments="off" show_pagination="off" fullwidth="on" use_overlay="off" background_layout="light" pagination_font_size_tablet="51" pagination_line_height_tablet="2" offset_number="1" /][/et_pb_column][et_pb_column type="1_3"][et_pb_blog global_parent="26303" _builder_version="3.0.106" posts_number="1" include_categories="36" show_content="off" show_thumbnail="off" show_more="on" show_author="off" show_date="off" show_categories="on" show_comments="off" show_pagination="off" fullwidth="on" use_overlay="off" background_layout="light" pagination_font_size_tablet="51" pagination_line_height_tablet="2" offset_number="2" /][/et_pb_column][/et_pb_row][/et_pb_section][et_pb_section bb_built="1" background_color="#2d79c2" module_class="cta-background" _builder_version="3.0.106" use_background_color_gradient="on" background_color_gradient_start="#296ab0" background_color_gradient_end="#2b71ba" background_color_gradient_type="radial" prev_background_color="#e6eaee" global_module="20823"][et_pb_row global_parent="20823" _builder_version="3.0.47" background_size="initial" background_position="top_left" background_repeat="repeat"][et_pb_column type="4_4"][et_pb_text global_parent="20823" background_layout="dark" _builder_version="3.0.106" text_font="|600|||||||" text_text_color="#ffffff" header_2_font_size="30px"]
Ready to learn more?
[/et_pb_text][/et_pb_column][/et_pb_row][et_pb_row global_parent="20823" module_class="callout-btns" _builder_version="3.0.106"][et_pb_column type="1_2"][et_pb_button global_parent="20823" button_url="/contact" button_text="Contact Us" background_layout="dark" module_class="footer-cta-btn" _builder_version="3.0.106" custom_button="on" button_text_size="17" button_text_color="#ffffff" button_bg_color="#66bf48" button_border_color="#66bf48" button_border_radius="5" button_use_icon="off"][/et_pb_button][/et_pb_column][et_pb_column type="1_2"][et_pb_button admin_label="Desktop Phone" global_parent="20823" button_text="1-877-624-2792" background_layout="dark" module_class="footer-cta-btn" _builder_version="3.2.2" custom_button="on" button_text_size="17" button_text_color="#ffffff" button_bg_color="#66bf48" button_border_color="#66bf48" button_border_radius="5" button_use_icon="off" disabled="off" disabled_on="on|on|" button_bg_color_hover="#66bf48" button_border_color_hover="#66bf48"]
[/et_pb_button][et_pb_button admin_label="Mobile Phone" global_parent="20823" button_url="tel:18005555555" button_text="1-877-624-2792" background_layout="dark" module_class="footer-cta-btn" _builder_version="3.2.2" custom_button="on" button_text_size="17" button_text_color="#ffffff" button_bg_color="#66bf48" button_border_color="#66bf48" button_border_radius="5" button_use_icon="off" disabled="off" disabled_on="||on"]
[/et_pb_button][et_pb_button global_parent="20823" button_url="#" button_text="Chat Now" background_layout="dark" module_id="chat-btn" module_class="footer-cta-btn" _builder_version="3.2.2" custom_button="on" button_text_size="17" button_text_color="#ffffff" button_bg_color="#66bf48" button_border_color="#66bf48" button_border_radius="5" button_use_icon="off" disabled_on="on|on|on" disabled="on"]
[/et_pb_button][/et_pb_column][/et_pb_row][/et_pb_section] [post_title] => Block listing Interim Review [post_excerpt] => [post_status] => publish [comment_status] => open [ping_status] => open [post_password] => [post_name] => block-listing-interim-review [to_ping] => [pinged] => [post_modified] => 2018-06-19 15:40:23 [post_modified_gmt] => 2018-06-19 15:40:23 [post_content_filtered] => [post_parent] => 0 [guid] => https://public.craneware.com/?p=30193 [menu_order] => 0 [post_type] => post [post_mime_type] => [comment_count] => 0 [filter] => raw ) ) [post_count] => 1 [current_post] => -1 [in_the_loop] => [post] => WP_Post Object ( [ID] => 30193 [post_author] => 2 [post_date] => 2018-04-17 15:33:37 [post_date_gmt] => 2018-04-17 15:33:37 [post_content] => [et_pb_section bb_built="1" next_background_color="#000000" _builder_version="3.0.106" module_class="article-post"][et_pb_row][et_pb_column type="4_4"][et_pb_text _builder_version="3.2.2"]
Schedule 6, Block Admission Period to 15 April 2018
This block admission announcement, as required by the AIM Rules, is made every six months and relates to the number of shares that have been issued and allotted during this six month period under the Company's block listing for approved share option plans.
| Name of the company | Craneware plc |
| Names of the schemes | Approved Share Option Plan 2007 |
| Period of return: | 16/10/2017 to 15/4/2018 |
| Balance of unallotted securities under scheme(s) from previous return: | Approved Share Option Plan 2007: 263,781 Ordinary Shares @ 1p each |
| Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | Approved Share Option Plan 2007: 200,000 Ordinary Shares @ 1p each |
| Less: Number of securities issued/allotted under scheme(s) during period: | Approved Share Option Plan 2007: 329,431 Ordinary Shares @ 1p each |
| Equals: Balance under scheme(s) not yet issued/allotted at end of period: | Approved Share Option Plan 2007: 134,350 Ordinary Shares @ 1p each |
| Number and class of securities originally admitted at the date of admission: | 24,929,950 Ordinary Shares of 1p each on 13 September 2007 |
| Contact name and telephone number: | Craig Preston +44 (0) 131 550 3100 |
Share the Love!
[/et_pb_text][et_pb_image global_parent="25686" src="https://craneware.wpengine.com/wp-content/uploads/2018/03/twitter-share.png" url="https://twitter.com/home?status=" align="center" module_class="share-icon twitter" _builder_version="3.2.2" /][et_pb_image global_parent="25686" src="https://craneware.wpengine.com/wp-content/uploads/2018/06/linkedin_share.png" url="https://www.linkedin.com/shareArticle?mini=true&url=" align="center" module_class="share-icon linkedin" _builder_version="3.2.2" /][/et_pb_column][/et_pb_row][/et_pb_section][et_pb_section bb_built="1" fullwidth="off" specialty="off" _builder_version="3.0.106" background_color="#e6eaee" module_class="related-background" prev_background_color="#ffffff" next_background_color="#2d79c2" global_module="26303"][et_pb_row global_parent="26303" background_position="top_left" background_repeat="repeat" background_size="initial"][et_pb_column type="4_4"][et_pb_text global_parent="26303" _builder_version="3.0.90" background_layout="light"]You might also like...
[/et_pb_text][/et_pb_column][/et_pb_row][et_pb_row global_parent="26303" background_position="top_left" background_repeat="repeat" background_size="initial"][et_pb_column type="1_3"][et_pb_blog global_parent="26303" _builder_version="3.0.106" posts_number="1" include_categories="36" show_content="off" show_thumbnail="off" show_more="on" show_author="off" show_date="off" show_categories="on" show_comments="off" show_pagination="off" fullwidth="on" use_overlay="off" background_layout="light" pagination_font_size_tablet="51" pagination_line_height_tablet="2" /][/et_pb_column][et_pb_column type="1_3"][et_pb_blog global_parent="26303" _builder_version="3.0.106" posts_number="1" include_categories="36" show_content="off" show_thumbnail="off" show_more="on" show_author="off" show_date="off" show_categories="on" show_comments="off" show_pagination="off" fullwidth="on" use_overlay="off" background_layout="light" pagination_font_size_tablet="51" pagination_line_height_tablet="2" offset_number="1" /][/et_pb_column][et_pb_column type="1_3"][et_pb_blog global_parent="26303" _builder_version="3.0.106" posts_number="1" include_categories="36" show_content="off" show_thumbnail="off" show_more="on" show_author="off" show_date="off" show_categories="on" show_comments="off" show_pagination="off" fullwidth="on" use_overlay="off" background_layout="light" pagination_font_size_tablet="51" pagination_line_height_tablet="2" offset_number="2" /][/et_pb_column][/et_pb_row][/et_pb_section][et_pb_section bb_built="1" background_color="#2d79c2" module_class="cta-background" _builder_version="3.0.106" use_background_color_gradient="on" background_color_gradient_start="#296ab0" background_color_gradient_end="#2b71ba" background_color_gradient_type="radial" prev_background_color="#e6eaee" global_module="20823"][et_pb_row global_parent="20823" _builder_version="3.0.47" background_size="initial" background_position="top_left" background_repeat="repeat"][et_pb_column type="4_4"][et_pb_text global_parent="20823" background_layout="dark" _builder_version="3.0.106" text_font="|600|||||||" text_text_color="#ffffff" header_2_font_size="30px"]
Ready to learn more?
[/et_pb_text][/et_pb_column][/et_pb_row][et_pb_row global_parent="20823" module_class="callout-btns" _builder_version="3.0.106"][et_pb_column type="1_2"][et_pb_button global_parent="20823" button_url="/contact" button_text="Contact Us" background_layout="dark" module_class="footer-cta-btn" _builder_version="3.0.106" custom_button="on" button_text_size="17" button_text_color="#ffffff" button_bg_color="#66bf48" button_border_color="#66bf48" button_border_radius="5" button_use_icon="off"][/et_pb_button][/et_pb_column][et_pb_column type="1_2"][et_pb_button admin_label="Desktop Phone" global_parent="20823" button_text="1-877-624-2792" background_layout="dark" module_class="footer-cta-btn" _builder_version="3.2.2" custom_button="on" button_text_size="17" button_text_color="#ffffff" button_bg_color="#66bf48" button_border_color="#66bf48" button_border_radius="5" button_use_icon="off" disabled="off" disabled_on="on|on|" button_bg_color_hover="#66bf48" button_border_color_hover="#66bf48"]
[/et_pb_button][et_pb_button admin_label="Mobile Phone" global_parent="20823" button_url="tel:18005555555" button_text="1-877-624-2792" background_layout="dark" module_class="footer-cta-btn" _builder_version="3.2.2" custom_button="on" button_text_size="17" button_text_color="#ffffff" button_bg_color="#66bf48" button_border_color="#66bf48" button_border_radius="5" button_use_icon="off" disabled="off" disabled_on="||on"]
[/et_pb_button][et_pb_button global_parent="20823" button_url="#" button_text="Chat Now" background_layout="dark" module_id="chat-btn" module_class="footer-cta-btn" _builder_version="3.2.2" custom_button="on" button_text_size="17" button_text_color="#ffffff" button_bg_color="#66bf48" button_border_color="#66bf48" button_border_radius="5" button_use_icon="off" disabled_on="on|on|on" disabled="on"]
[/et_pb_button][/et_pb_column][/et_pb_row][/et_pb_section] [post_title] => Block listing Interim Review [post_excerpt] => [post_status] => publish [comment_status] => open [ping_status] => open [post_password] => [post_name] => block-listing-interim-review [to_ping] => [pinged] => [post_modified] => 2018-06-19 15:40:23 [post_modified_gmt] => 2018-06-19 15:40:23 [post_content_filtered] => [post_parent] => 0 [guid] => https://public.craneware.com/?p=30193 [menu_order] => 0 [post_type] => post [post_mime_type] => [comment_count] => 0 [filter] => raw ) [comment_count] => 0 [current_comment] => -1 [found_posts] => 193 [max_num_pages] => 193 [max_num_comment_pages] => 0 [is_single] => [is_preview] => [is_page] => [is_archive] => 1 [is_date] => [is_year] => [is_month] => [is_day] => [is_time] => [is_author] => [is_category] => 1 [is_tag] => [is_tax] => [is_search] => [is_feed] => [is_comment_feed] => [is_trackback] => [is_home] => [is_404] => [is_embed] => [is_paged] => [is_admin] => [is_attachment] => [is_singular] => [is_robots] => [is_posts_page] => [is_post_type_archive] => [query_vars_hash:WP_Query:private] => d5233108f47c5d9825e861299022864e [query_vars_changed:WP_Query:private] => [thumbnails_cached] => [stopwords:WP_Query:private] => [compat_fields:WP_Query:private] => Array ( [0] => query_vars_hash [1] => query_vars_changed ) [compat_methods:WP_Query:private] => Array ( [0] => init_query_flags [1] => parse_tax_query ) )
Block listing Interim Review
Apr 17, 2018 | Announcements
Schedule 6, Block Admission Period to 15 April 2018 This block admission announcement, as required by the AIM Rules, is made every six months and relates to the number of shares that have been issued and allotted during this six month...
read moreArray
(
[posts_per_page] => 1
[cat] => 36
[paged] => 1
[offset] => 2
[post__not_in] => Array
(
[0] => 353
)
)
WP_Query Object
(
[query] => Array
(
[posts_per_page] => 1
[cat] => 36
[paged] => 1
[offset] => 2
[post__not_in] => Array
(
[0] => 353
)
)
[query_vars] => Array
(
[posts_per_page] => 1
[cat] => 36
[paged] => 1
[offset] => 2
[post__not_in] => Array
(
[0] => 353
)
[error] =>
[m] =>
[p] => 0
[post_parent] =>
[subpost] =>
[subpost_id] =>
[attachment] =>
[attachment_id] => 0
[name] =>
[static] =>
[pagename] =>
[page_id] => 0
[second] =>
[minute] =>
[hour] =>
[day] => 0
[monthnum] => 0
[year] => 0
[w] => 0
[category_name] => announcements
[tag] =>
[tag_id] =>
[author] =>
[author_name] =>
[feed] =>
[tb] =>
[meta_key] =>
[meta_value] =>
[preview] =>
[s] =>
[sentence] =>
[title] =>
[fields] =>
[menu_order] =>
[embed] =>
[category__in] => Array
(
)
[category__not_in] => Array
(
)
[category__and] => Array
(
)
[post__in] => Array
(
)
[post_name__in] => Array
(
)
[tag__in] => Array
(
)
[tag__not_in] => Array
(
)
[tag__and] => Array
(
)
[tag_slug__in] => Array
(
)
[tag_slug__and] => Array
(
)
[post_parent__in] => Array
(
)
[post_parent__not_in] => Array
(
)
[author__in] => Array
(
)
[author__not_in] => Array
(
)
[ignore_sticky_posts] =>
[suppress_filters] =>
[cache_results] => 1
[update_post_term_cache] => 1
[lazy_load_term_meta] => 1
[update_post_meta_cache] => 1
[post_type] =>
[nopaging] =>
[comments_per_page] => 50
[no_found_rows] =>
[order] => DESC
)
[tax_query] => WP_Tax_Query Object
(
[queries] => Array
(
[0] => Array
(
[taxonomy] => category
[terms] => Array
(
[0] => 36
)
[field] => term_id
[operator] => IN
[include_children] => 1
)
)
[relation] => AND
[table_aliases:protected] => Array
(
[0] => wp_term_relationships
)
[queried_terms] => Array
(
[category] => Array
(
[terms] => Array
(
[0] => 36
)
[field] => term_id
)
)
[primary_table] => wp_posts
[primary_id_column] => ID
)
[meta_query] => WP_Meta_Query Object
(
[queries] => Array
(
)
[relation] =>
[meta_table] =>
[meta_id_column] =>
[primary_table] =>
[primary_id_column] =>
[table_aliases:protected] => Array
(
)
[clauses:protected] => Array
(
)
[has_or_relation:protected] =>
)
[date_query] =>
[request] => SELECT SQL_CALC_FOUND_ROWS wp_posts.ID FROM wp_posts LEFT JOIN wp_term_relationships ON (wp_posts.ID = wp_term_relationships.object_id) WHERE 1=1 AND wp_posts.ID NOT IN (353) AND (
wp_term_relationships.term_taxonomy_id IN (36)
) AND wp_posts.post_type = 'post' AND (wp_posts.post_status = 'publish') GROUP BY wp_posts.ID ORDER BY wp_posts.post_date DESC LIMIT 2, 1
[posts] => Array
(
[0] => WP_Post Object
(
[ID] => 30197
[post_author] => 2
[post_date] => 2018-04-11 15:45:16
[post_date_gmt] => 2018-04-11 15:45:16
[post_content] => [et_pb_section bb_built="1" next_background_color="#000000" _builder_version="3.0.106" module_class="article-post"][et_pb_row][et_pb_column type="4_4"][et_pb_text _builder_version="3.2.2"]
TR-1: Standard form for notification of major holdings
| NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i | |||||||||
| 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii | CRANEWARE PLC | ||||||||
| 1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate) | |||||||||
| Non-UK issuer | |||||||||
| 2. Reason for the notification (please tick the appropriate box or boxes): | |||||||||
| An acquisition or disposal of voting rights | X | ||||||||
| An acquisition or disposal of financial instruments | |||||||||
| An event changing the breakdown of voting rights | |||||||||
| Other (please specify)iii: Stock lending | |||||||||
| 3. Details of person subject to the notification obligation iv | |||||||||
| Name | CANACCORD GENUITY GROUP INC | ||||||||
| City and country of registered office (if applicable) | VANCOUVER, CANADA | ||||||||
| 4. Full name of shareholder(s) (if different from 3.) v | |||||||||
| Name | DISCRETIONARY CLIENTS | ||||||||
| City and country of registered office (if applicable) | As above | ||||||||
| 5. Date on which the threshold was crossed or reached vi: | 10 APRIL 2018 | ||||||||
| 6. Date on which issuer notified (DD/MM/YYYY): | 10 APRIL 2018 | ||||||||
| 7. Total positions of person(s) subject to the notification obligation | |||||||||
| % of voting rights attached to shares (total of 8. A) | % of voting rights through financial instruments (total of 8.B 1 + 8.B 2) | Total of both in % (8.A + 8.B) | Total number of voting rights of issuer vii | ||||||
| Resulting situation on the date on which threshold was crossed or reached | 11.0691 | N/A | 11.0691 | 26,662,271 | |||||
| Position of previous notification (if applicable) | 10.9810 | N/A | 10.9810 | ||||||
| 8. Notified details of the resulting situation on the date on which the threshold was crossed or reached viii | |||||||||
| A: Voting rights attached to shares | |||||||||
| Class/type of shares | Number of voting rights ix | % of voting rights | |||||||
| ISIN code (if possible) | Direct (Art 9 of Directive 2004/109/EC) (DTR5.1) | Indirect (Art 10 of Directive 2004/109/EC) (DTR5.2.1) | Direct (Art 9 of Directive 2004/109/EC) (DTR5.1) | Direct (Art 10 of Directive 2004/109/EC) (DTR5.2.1)xi | |||||
| GB00B2425G68 | 2,951,286 | 11.0691 | |||||||
| SUBTOTAL 8.A | 2,951,286 | 11.0691 | |||||||
| B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a)) | |||||||||
| Type of financial instrument | Expiration date x | Exercise/ Conversion Period xi | Number of voting rights that may be acquired if the instrument is exercised/ converted. | % of voting rights | |||||
| SUBTOTAL 8. B 1 | |||||||||
| B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b)) | |||||||||
| Type of financial instrument | Expiration date x | Exercise/Conversion Period xi | Physical or cash settlement xii | Number of voting rights | % of voting rights | ||||
| SUBTOTAL 8.B.2 | |||||||||
| 9. Information in relation to the person subject to the notification obligation (please mark the applicable box with an "X") | |||||||||
| Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer xiii | |||||||||
| Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary) | X | ||||||||
| Name xv | % of voting rights if it equals or is higher than the notifiable threshold | % of voting rights through financial instruments if it equals or is higher than the notifiable threshold | Total of both if it equals or is higher than the notifiable threshold | ||||||
| Canaccord Genuity Group Inc. | 11.0691 | 11.0691 | |||||||
| Canaccord Genuity Wealth Group Holdings Limited | 11.0691 | 11.0691 | |||||||
| Canaccord Genuity Wealth Group Holdings (Jersey) Limited | 11.0691 | 11.0691 | |||||||
| Hargreave Hale Ltd | 10.4280 | 10.4280 | |||||||
| Canaccord Genuity Wealth Group Limited | 0.6411 | 0.6411 | |||||||
| Canaccord Genuity Wealth Limited | 0.6411 | 0.6411 | |||||||
| 10. In case of proxy voting, please identify: | |||||||||
| Name of the proxy holder | N/A | ||||||||
| The number and % of voting rights held | N/A | ||||||||
| The date until which the voting rights will be held | N/A | ||||||||
| 11. Additional information xvi | |||||||||
| Place of completion | BLACKPOOL, ENGLAND | ||||||||
| Date of completion | 11 APRIL 2018 | ||||||||
Share the Love!
[/et_pb_text][et_pb_image global_parent="25686" src="https://craneware.wpengine.com/wp-content/uploads/2018/03/twitter-share.png" url="https://twitter.com/home?status=" align="center" module_class="share-icon twitter" _builder_version="3.2.2" /][et_pb_image global_parent="25686" src="https://craneware.wpengine.com/wp-content/uploads/2018/06/linkedin_share.png" url="https://www.linkedin.com/shareArticle?mini=true&url=" align="center" module_class="share-icon linkedin" _builder_version="3.2.2" /][/et_pb_column][/et_pb_row][/et_pb_section][et_pb_section bb_built="1" fullwidth="off" specialty="off" _builder_version="3.0.106" background_color="#e6eaee" module_class="related-background" prev_background_color="#ffffff" next_background_color="#2d79c2" global_module="26303"][et_pb_row global_parent="26303" background_position="top_left" background_repeat="repeat" background_size="initial"][et_pb_column type="4_4"][et_pb_text global_parent="26303" _builder_version="3.0.90" background_layout="light"]You might also like...
[/et_pb_text][/et_pb_column][/et_pb_row][et_pb_row global_parent="26303" background_position="top_left" background_repeat="repeat" background_size="initial"][et_pb_column type="1_3"][et_pb_blog global_parent="26303" _builder_version="3.0.106" posts_number="1" include_categories="36" show_content="off" show_thumbnail="off" show_more="on" show_author="off" show_date="off" show_categories="on" show_comments="off" show_pagination="off" fullwidth="on" use_overlay="off" background_layout="light" pagination_font_size_tablet="51" pagination_line_height_tablet="2" /][/et_pb_column][et_pb_column type="1_3"][et_pb_blog global_parent="26303" _builder_version="3.0.106" posts_number="1" include_categories="36" show_content="off" show_thumbnail="off" show_more="on" show_author="off" show_date="off" show_categories="on" show_comments="off" show_pagination="off" fullwidth="on" use_overlay="off" background_layout="light" pagination_font_size_tablet="51" pagination_line_height_tablet="2" offset_number="1" /][/et_pb_column][et_pb_column type="1_3"][et_pb_blog global_parent="26303" _builder_version="3.0.106" posts_number="1" include_categories="36" show_content="off" show_thumbnail="off" show_more="on" show_author="off" show_date="off" show_categories="on" show_comments="off" show_pagination="off" fullwidth="on" use_overlay="off" background_layout="light" pagination_font_size_tablet="51" pagination_line_height_tablet="2" offset_number="2" /][/et_pb_column][/et_pb_row][/et_pb_section][et_pb_section bb_built="1" background_color="#2d79c2" module_class="cta-background" _builder_version="3.0.106" use_background_color_gradient="on" background_color_gradient_start="#296ab0" background_color_gradient_end="#2b71ba" background_color_gradient_type="radial" prev_background_color="#e6eaee" global_module="20823"][et_pb_row global_parent="20823" _builder_version="3.0.47" background_size="initial" background_position="top_left" background_repeat="repeat"][et_pb_column type="4_4"][et_pb_text global_parent="20823" background_layout="dark" _builder_version="3.0.106" text_font="|600|||||||" text_text_color="#ffffff" header_2_font_size="30px"]
Ready to learn more?
[/et_pb_text][/et_pb_column][/et_pb_row][et_pb_row global_parent="20823" module_class="callout-btns" _builder_version="3.0.106"][et_pb_column type="1_2"][et_pb_button global_parent="20823" button_url="/contact" button_text="Contact Us" background_layout="dark" module_class="footer-cta-btn" _builder_version="3.0.106" custom_button="on" button_text_size="17" button_text_color="#ffffff" button_bg_color="#66bf48" button_border_color="#66bf48" button_border_radius="5" button_use_icon="off"][/et_pb_button][/et_pb_column][et_pb_column type="1_2"][et_pb_button admin_label="Desktop Phone" global_parent="20823" button_text="1-877-624-2792" background_layout="dark" module_class="footer-cta-btn" _builder_version="3.2.2" custom_button="on" button_text_size="17" button_text_color="#ffffff" button_bg_color="#66bf48" button_border_color="#66bf48" button_border_radius="5" button_use_icon="off" disabled="off" disabled_on="on|on|" button_bg_color_hover="#66bf48" button_border_color_hover="#66bf48"]
[/et_pb_button][et_pb_button admin_label="Mobile Phone" global_parent="20823" button_url="tel:18005555555" button_text="1-877-624-2792" background_layout="dark" module_class="footer-cta-btn" _builder_version="3.2.2" custom_button="on" button_text_size="17" button_text_color="#ffffff" button_bg_color="#66bf48" button_border_color="#66bf48" button_border_radius="5" button_use_icon="off" disabled="off" disabled_on="||on"]
[/et_pb_button][et_pb_button global_parent="20823" button_url="#" button_text="Chat Now" background_layout="dark" module_id="chat-btn" module_class="footer-cta-btn" _builder_version="3.2.2" custom_button="on" button_text_size="17" button_text_color="#ffffff" button_bg_color="#66bf48" button_border_color="#66bf48" button_border_radius="5" button_use_icon="off" disabled_on="on|on|on" disabled="on"]
[/et_pb_button][/et_pb_column][/et_pb_row][/et_pb_section] [post_title] => Holding(s) in Company [post_excerpt] => [post_status] => publish [comment_status] => open [ping_status] => open [post_password] => [post_name] => holdings-in-company [to_ping] => [pinged] => [post_modified] => 2018-06-19 15:51:22 [post_modified_gmt] => 2018-06-19 15:51:22 [post_content_filtered] => [post_parent] => 0 [guid] => https://public.craneware.com/?p=30197 [menu_order] => 0 [post_type] => post [post_mime_type] => [comment_count] => 0 [filter] => raw ) ) [post_count] => 1 [current_post] => -1 [in_the_loop] => [post] => WP_Post Object ( [ID] => 30197 [post_author] => 2 [post_date] => 2018-04-11 15:45:16 [post_date_gmt] => 2018-04-11 15:45:16 [post_content] => [et_pb_section bb_built="1" next_background_color="#000000" _builder_version="3.0.106" module_class="article-post"][et_pb_row][et_pb_column type="4_4"][et_pb_text _builder_version="3.2.2"]
TR-1: Standard form for notification of major holdings
| NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i | |||||||||
| 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii | CRANEWARE PLC | ||||||||
| 1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate) | |||||||||
| Non-UK issuer | |||||||||
| 2. Reason for the notification (please tick the appropriate box or boxes): | |||||||||
| An acquisition or disposal of voting rights | X | ||||||||
| An acquisition or disposal of financial instruments | |||||||||
| An event changing the breakdown of voting rights | |||||||||
| Other (please specify)iii: Stock lending | |||||||||
| 3. Details of person subject to the notification obligation iv | |||||||||
| Name | CANACCORD GENUITY GROUP INC | ||||||||
| City and country of registered office (if applicable) | VANCOUVER, CANADA | ||||||||
| 4. Full name of shareholder(s) (if different from 3.) v | |||||||||
| Name | DISCRETIONARY CLIENTS | ||||||||
| City and country of registered office (if applicable) | As above | ||||||||
| 5. Date on which the threshold was crossed or reached vi: | 10 APRIL 2018 | ||||||||
| 6. Date on which issuer notified (DD/MM/YYYY): | 10 APRIL 2018 | ||||||||
| 7. Total positions of person(s) subject to the notification obligation | |||||||||
| % of voting rights attached to shares (total of 8. A) | % of voting rights through financial instruments (total of 8.B 1 + 8.B 2) | Total of both in % (8.A + 8.B) | Total number of voting rights of issuer vii | ||||||
| Resulting situation on the date on which threshold was crossed or reached | 11.0691 | N/A | 11.0691 | 26,662,271 | |||||
| Position of previous notification (if applicable) | 10.9810 | N/A | 10.9810 | ||||||
| 8. Notified details of the resulting situation on the date on which the threshold was crossed or reached viii | |||||||||
| A: Voting rights attached to shares | |||||||||
| Class/type of shares | Number of voting rights ix | % of voting rights | |||||||
| ISIN code (if possible) | Direct (Art 9 of Directive 2004/109/EC) (DTR5.1) | Indirect (Art 10 of Directive 2004/109/EC) (DTR5.2.1) | Direct (Art 9 of Directive 2004/109/EC) (DTR5.1) | Direct (Art 10 of Directive 2004/109/EC) (DTR5.2.1)xi | |||||
| GB00B2425G68 | 2,951,286 | 11.0691 | |||||||
| SUBTOTAL 8.A | 2,951,286 | 11.0691 | |||||||
| B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a)) | |||||||||
| Type of financial instrument | Expiration date x | Exercise/ Conversion Period xi | Number of voting rights that may be acquired if the instrument is exercised/ converted. | % of voting rights | |||||
| SUBTOTAL 8. B 1 | |||||||||
| B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b)) | |||||||||
| Type of financial instrument | Expiration date x | Exercise/Conversion Period xi | Physical or cash settlement xii | Number of voting rights | % of voting rights | ||||
| SUBTOTAL 8.B.2 | |||||||||
| 9. Information in relation to the person subject to the notification obligation (please mark the applicable box with an "X") | |||||||||
| Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer xiii | |||||||||
| Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary) | X | ||||||||
| Name xv | % of voting rights if it equals or is higher than the notifiable threshold | % of voting rights through financial instruments if it equals or is higher than the notifiable threshold | Total of both if it equals or is higher than the notifiable threshold | ||||||
| Canaccord Genuity Group Inc. | 11.0691 | 11.0691 | |||||||
| Canaccord Genuity Wealth Group Holdings Limited | 11.0691 | 11.0691 | |||||||
| Canaccord Genuity Wealth Group Holdings (Jersey) Limited | 11.0691 | 11.0691 | |||||||
| Hargreave Hale Ltd | 10.4280 | 10.4280 | |||||||
| Canaccord Genuity Wealth Group Limited | 0.6411 | 0.6411 | |||||||
| Canaccord Genuity Wealth Limited | 0.6411 | 0.6411 | |||||||
| 10. In case of proxy voting, please identify: | |||||||||
| Name of the proxy holder | N/A | ||||||||
| The number and % of voting rights held | N/A | ||||||||
| The date until which the voting rights will be held | N/A | ||||||||
| 11. Additional information xvi | |||||||||
| Place of completion | BLACKPOOL, ENGLAND | ||||||||
| Date of completion | 11 APRIL 2018 | ||||||||
Share the Love!
[/et_pb_text][et_pb_image global_parent="25686" src="https://craneware.wpengine.com/wp-content/uploads/2018/03/twitter-share.png" url="https://twitter.com/home?status=" align="center" module_class="share-icon twitter" _builder_version="3.2.2" /][et_pb_image global_parent="25686" src="https://craneware.wpengine.com/wp-content/uploads/2018/06/linkedin_share.png" url="https://www.linkedin.com/shareArticle?mini=true&url=" align="center" module_class="share-icon linkedin" _builder_version="3.2.2" /][/et_pb_column][/et_pb_row][/et_pb_section][et_pb_section bb_built="1" fullwidth="off" specialty="off" _builder_version="3.0.106" background_color="#e6eaee" module_class="related-background" prev_background_color="#ffffff" next_background_color="#2d79c2" global_module="26303"][et_pb_row global_parent="26303" background_position="top_left" background_repeat="repeat" background_size="initial"][et_pb_column type="4_4"][et_pb_text global_parent="26303" _builder_version="3.0.90" background_layout="light"]You might also like...
[/et_pb_text][/et_pb_column][/et_pb_row][et_pb_row global_parent="26303" background_position="top_left" background_repeat="repeat" background_size="initial"][et_pb_column type="1_3"][et_pb_blog global_parent="26303" _builder_version="3.0.106" posts_number="1" include_categories="36" show_content="off" show_thumbnail="off" show_more="on" show_author="off" show_date="off" show_categories="on" show_comments="off" show_pagination="off" fullwidth="on" use_overlay="off" background_layout="light" pagination_font_size_tablet="51" pagination_line_height_tablet="2" /][/et_pb_column][et_pb_column type="1_3"][et_pb_blog global_parent="26303" _builder_version="3.0.106" posts_number="1" include_categories="36" show_content="off" show_thumbnail="off" show_more="on" show_author="off" show_date="off" show_categories="on" show_comments="off" show_pagination="off" fullwidth="on" use_overlay="off" background_layout="light" pagination_font_size_tablet="51" pagination_line_height_tablet="2" offset_number="1" /][/et_pb_column][et_pb_column type="1_3"][et_pb_blog global_parent="26303" _builder_version="3.0.106" posts_number="1" include_categories="36" show_content="off" show_thumbnail="off" show_more="on" show_author="off" show_date="off" show_categories="on" show_comments="off" show_pagination="off" fullwidth="on" use_overlay="off" background_layout="light" pagination_font_size_tablet="51" pagination_line_height_tablet="2" offset_number="2" /][/et_pb_column][/et_pb_row][/et_pb_section][et_pb_section bb_built="1" background_color="#2d79c2" module_class="cta-background" _builder_version="3.0.106" use_background_color_gradient="on" background_color_gradient_start="#296ab0" background_color_gradient_end="#2b71ba" background_color_gradient_type="radial" prev_background_color="#e6eaee" global_module="20823"][et_pb_row global_parent="20823" _builder_version="3.0.47" background_size="initial" background_position="top_left" background_repeat="repeat"][et_pb_column type="4_4"][et_pb_text global_parent="20823" background_layout="dark" _builder_version="3.0.106" text_font="|600|||||||" text_text_color="#ffffff" header_2_font_size="30px"]
Ready to learn more?
[/et_pb_text][/et_pb_column][/et_pb_row][et_pb_row global_parent="20823" module_class="callout-btns" _builder_version="3.0.106"][et_pb_column type="1_2"][et_pb_button global_parent="20823" button_url="/contact" button_text="Contact Us" background_layout="dark" module_class="footer-cta-btn" _builder_version="3.0.106" custom_button="on" button_text_size="17" button_text_color="#ffffff" button_bg_color="#66bf48" button_border_color="#66bf48" button_border_radius="5" button_use_icon="off"][/et_pb_button][/et_pb_column][et_pb_column type="1_2"][et_pb_button admin_label="Desktop Phone" global_parent="20823" button_text="1-877-624-2792" background_layout="dark" module_class="footer-cta-btn" _builder_version="3.2.2" custom_button="on" button_text_size="17" button_text_color="#ffffff" button_bg_color="#66bf48" button_border_color="#66bf48" button_border_radius="5" button_use_icon="off" disabled="off" disabled_on="on|on|" button_bg_color_hover="#66bf48" button_border_color_hover="#66bf48"]
[/et_pb_button][et_pb_button admin_label="Mobile Phone" global_parent="20823" button_url="tel:18005555555" button_text="1-877-624-2792" background_layout="dark" module_class="footer-cta-btn" _builder_version="3.2.2" custom_button="on" button_text_size="17" button_text_color="#ffffff" button_bg_color="#66bf48" button_border_color="#66bf48" button_border_radius="5" button_use_icon="off" disabled="off" disabled_on="||on"]
[/et_pb_button][et_pb_button global_parent="20823" button_url="#" button_text="Chat Now" background_layout="dark" module_id="chat-btn" module_class="footer-cta-btn" _builder_version="3.2.2" custom_button="on" button_text_size="17" button_text_color="#ffffff" button_bg_color="#66bf48" button_border_color="#66bf48" button_border_radius="5" button_use_icon="off" disabled_on="on|on|on" disabled="on"]
[/et_pb_button][/et_pb_column][/et_pb_row][/et_pb_section] [post_title] => Holding(s) in Company [post_excerpt] => [post_status] => publish [comment_status] => open [ping_status] => open [post_password] => [post_name] => holdings-in-company [to_ping] => [pinged] => [post_modified] => 2018-06-19 15:51:22 [post_modified_gmt] => 2018-06-19 15:51:22 [post_content_filtered] => [post_parent] => 0 [guid] => https://public.craneware.com/?p=30197 [menu_order] => 0 [post_type] => post [post_mime_type] => [comment_count] => 0 [filter] => raw ) [comment_count] => 0 [current_comment] => -1 [found_posts] => 193 [max_num_pages] => 193 [max_num_comment_pages] => 0 [is_single] => [is_preview] => [is_page] => [is_archive] => 1 [is_date] => [is_year] => [is_month] => [is_day] => [is_time] => [is_author] => [is_category] => 1 [is_tag] => [is_tax] => [is_search] => [is_feed] => [is_comment_feed] => [is_trackback] => [is_home] => [is_404] => [is_embed] => [is_paged] => [is_admin] => [is_attachment] => [is_singular] => [is_robots] => [is_posts_page] => [is_post_type_archive] => [query_vars_hash:WP_Query:private] => f5c93844e099565628c4aca42c558b9a [query_vars_changed:WP_Query:private] => [thumbnails_cached] => [stopwords:WP_Query:private] => [compat_fields:WP_Query:private] => Array ( [0] => query_vars_hash [1] => query_vars_changed ) [compat_methods:WP_Query:private] => Array ( [0] => init_query_flags [1] => parse_tax_query ) )
Holding(s) in Company
Apr 11, 2018 | Announcements
TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of...
read more